Ukax mä juk’a pachanakanwa

Slzii.com Thaqhata

Thaqhata (Yatiyawinaka)

Novartis Vanrafia® Phase III Data Support Slowing Of Kidney Function Decline In Patients With Iga Nephropathy

health top

(MENAFN - GlobeNewsWire - Nasdaq) In ALIGN study, Vanrafia (atrasentan) showed positive difference in eGFR change from baseline vs. placebo at Week 136, 4 weeks after study treatment ended1 ...
2026-02-13 01:16:40

Kuns lurtä?
0.094190835952759


Yatiyawinaka
Yatiyawinaka

Qhipa Yatiyäwinaka ukat Titulos ukanaka
(MENAFN - GlobeNewsWire - Nasdaq) In ALIGN study, Vanrafia (atrasentan) showed positive difference in eGFR change from baseline vs. placebo ...
Yatiyawinaka